EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Recent evolution of risk analyses in atomic bomb survivor studies: new methods and applications

John Cologne iD, Munechika Misumi iD, Hanna Lindner iD, Zhenqiu Liu iD, Richard Sposto iD

Carcinogenesis · 2025

DOI: 10.1093/carcin/bgaf043 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Carcinogenesis, 2025. Verfasst von John Cologne und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics, Radiation Effects Research Foundation, Hiroshima 732-0815, Japan. Hauptthemen laut MEDLINE: Atomic Bomb Survivors, Neoplasms, Radiation-Induced. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Radiation Effects Research Foundation, Japanese Ministry of Health, Labour and Welfare, US Department of Energy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several decades ago a dramatic leap forward occurred in the development and application of statistical methods for modeling radiation risk at the Radiation Effects Research Foundation (RERF). Poisson regression analysis for grouped person-year cohort data and the linear excess relative risk model were introduced, and subsequently a devoted software system, Epicure® (https://www.hirosoft.com), was developed by researchers at RERF and at the U.S. National Cancer Institute. Numerous advancements in understanding radiation effects on humans were made possible with these methods, which are still the state-of-the-art for risk assessment at RERF and have remained part of the standard toolbox for radiation—and other environmental—epidemiological studies worldwide. Nevertheless, as our understanding of radiation risk has increased, so have the breadth and depth of questions that require answers based on emerging data that are not amenable to these conventional methods. This overview briefly recounts the conventional methods and then describes our recent diversification into the use or development of new statistical approaches to meet the challenges of burgeoning biological data and emerging mechanistic information. We briefly discuss the development and application of new methods, current and planned, that are part of the RERF Statistics Department’s role in supporting institution-wide research, especially in our collaborations involving the Life Span Study, Adult Health Study, and First-generation Offspring Clinical Study. Some approaches to modeling and assessing radiation risk with newer methods mentioned herein have already been published, while some are still in development or are only beginning at the proposal stage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atomic Bomb SurvivorsNeoplasms, Radiation-InducedHumansRisk AssessmentNuclear Weapons

Stichwörter der Autor:innen

atomic-bomb survivorsradiation riskstatistical methods

Autor:innen und Institutionen

  • Department of Statistics, Radiation Effects Research Foundation, Hiroshima 732-0815, Japan.

ORCID-Profile: John Cologne, Munechika Misumi, Hanna Lindner, Zhenqiu Liu, Richard Sposto

Förderung

  • Radiation Effects Research Foundation
  • Japanese Ministry of Health, Labour and Welfare
  • US Department of Energy
  • National Academy of Sciences

Zitieren

APA

Cologne, J., Misumi, M., Lindner, H., Liu, Z., & Sposto, R. (2025). Recent evolution of risk analyses in atomic bomb survivor studies: new methods and applications. Carcinogenesis. https://doi.org/10.1093/carcin/bgaf043

Vancouver

Cologne J, Misumi M, Lindner H, Liu Z, Sposto R. Recent evolution of risk analyses in atomic bomb survivor studies: new methods and applications. Carcinogenesis. 2025. doi:10.1093/carcin/bgaf043

BibTeX
@article{Cologne2025,
  author = {Cologne, John and Misumi, Munechika and Lindner, Hanna and Liu, Zhenqiu and Sposto, Richard},
  title = {Recent evolution of risk analyses in atomic bomb survivor studies: new methods and applications},
  journal = {Carcinogenesis},
  year = {2025},
  doi = {10.1093/carcin/bgaf043}
}
Kostenlos starten →